The management of cor pulmonale

Area of Science:

• Cardiology
• Pulmonology
• Internal Medicine

Background:

• Pulmonary artery hypertension (PAH) is defined as elevated mean pulmonary pressure.
• This condition can lead to cor pulmonale (right ventricular enlargement) and subsequent right-sided heart failure.
• PAH can be idiopathic or secondary to various lung diseases, circulatory issues, or systemic conditions.

Purpose of the Study:

• To summarize the pathophysiology and management of cor pulmonale secondary to pulmonary artery hypertension.
• To review current and potential therapeutic strategies.

Main Methods:

• Literature review of pulmonary artery hypertension and cor pulmonale.
• Analysis of treatment modalities including oxygen, mechanical ventilation, and pharmacologic agents.
• Evaluation of the role of digoxin, inotropic agents, ACE inhibitors, and anticoagulation.

Main Results:

• Cor pulmonale results from the right ventricle's inability to compensate for increased pulmonary pressure.
• Standard treatments for cor pulmonale include oxygen and mechanical ventilation.
• Pulmonary vasodilators require cautious use due to potential gas exchange impairment.
• Digoxin and inotropic agents have been studied, while ACE inhibitors show limited acute utility.
• Anticoagulation may reduce mortality in specific patient groups.

Conclusions:

• Cor pulmonale management requires addressing the underlying pulmonary artery hypertension.
• Treatment strategies are tailored to the cause and severity, with careful consideration of potential complications.
• Anticoagulation represents a potential mortality-reducing intervention in select cases.